Works matching IS 10781552 AND DT 2013 AND VI 19 AND IP 4

Results: 18

Cost savings realized by use of the PhaSeal® closed-system transfer device for preparation of antineoplastic agents.

Published in:

2013

By:

Edwards, Michael S;
Solimando, Dominic A;
Grollman, Franklin R;
Pang, Janet L;
Chasick, Ashley H;
Hightman, Charlene M;
Johnson, Anthony D;
Mickens, Maxine G;
Preston, Lorenzo M

Publication type:

Journal Article

A retrospective study of patients’ out-of-pocket costs for granulocyte colony-stimulating factors.

Published in:

2013

By:

Tomic, Karen;
Long, Stacey;
Li, Xiaoyan;
Fu, An-Chen;
Yu, Tzy-Chyi;
Barron, Richard

Publication type:

Journal Article

Cost savings realized by use of the PhaSeal® closed-system transfer device for preparation of antineoplastic agents.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 338, doi. 10.1177/1078155213499387

By:

Edwards, Michael S;
Solimando, Dominic A;
Grollman, Franklin R;
Pang, Janet L;
Chasick, Ashley H;
Hightman, Charlene M;
Johnson, Anthony D;
Mickens, Maxine G;
Preston, Lorenzo M

Publication type:

Article

Muehrcke’s lines (Leukonychia striata) due to transretinoic acid therapy for acute promyelocytic leukemia.

Published in:

2013

By:

Dasanu, Constantin A;
Ichim, Thomas E;
Alexandrescu, Doru T

Publication type:

Journal Article

Reviewers List.

Published in:: Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 384, doi. 10.1177/1078155213509756
Publication type:: Article

Syndrome of Inappropriate Antidiuretic Hormone after vinorelbine treatment.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 380, doi. 10.1177/1078155212473003

By:

Hoang, Mai;
Varughese, Joyce;
Ratner, Elena

Publication type:

Article

A retrospective study of patients’ out-of-pocket costs for granulocyte colony-stimulating factors.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 328, doi. 10.1177/1078155212473001

By:

Tomic, Karen;
Long, Stacey;
Li, Xiaoyan;
Fu, An-Chen;
Yu, Tzy-Chyi;
Barron, Richard

Publication type:

Article

Methotrexate nephrotoxicity: Novel treatment, new approach.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 373, doi. 10.1177/1078155212473002

By:

Iqbal, Saima;
Armaghani, Avan;
Aiyer, Ravi;
Kazory, Amir

Publication type:

Article

Carfilzomib: A new proteasome inhibitor for relapsed or refractory multiple myeloma.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 348, doi. 10.1177/1078155212470388

By:

Steele, Jason M

Publication type:

Article

Romiplostim resistance in secondary failure of platelet recovery.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 369, doi. 10.1177/1078155212469640

By:

DeRemer, David L;
Katsanevas, Katerina;
Bradley, Amber;
Awan, Farrukh T

Publication type:

Article

Impact of temozolomide on gonadal function in patients with primary malignant brain tumors.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 321, doi. 10.1177/1078155212469243

By:

Strowd, RE;
Blackwood, R;
Brown, M;
Harmon, M;
Lovato, J;
Yalcinkaya, T;
Lesser, G

Publication type:

Article

Development of a closed drug preparation method for oral anticancer drugs.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 315, doi. 10.1177/1078155212467554

By:

Wakui, Nobuyuki;
Ookubo, Tetuo;
Iwasaki, Yusuke;
Ito, Rie;
Saito, Koichi;
Nakazawa, Hiroyuki

Publication type:

Article

Muehrcke’s lines (Leukonychia striata) due to transretinoic acid therapy for acute promyelocytic leukemia.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 377, doi. 10.1177/1078155212468923

By:

Dasanu, Constantin A;
Ichim, Thomas E;
Alexandrescu, Doru T

Publication type:

Article

Case report of interstitial nephritis induced by bevacizumab therapy for glioblastoma multiforme.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 365, doi. 10.1177/1078155212466421

By:

Lomax, Anna J;
Hill, Prue A;
Ashley, David M

Publication type:

Article

Adverse drug events resulting in admission to the intensive care unit in oncology patients: Incidence, characteristics and associated cost.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 298, doi. 10.1177/1078155212465995

By:

Nazer, Lama H;
Eljaber, Rana;
Rimawi, Dalia;
Hawari, Feras I

Publication type:

Article

Retrospective analysis of fluoroquinolone prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 291, doi. 10.1177/1078155212465215

By:

Simondsen, Katherine A;
Reed, Michael P;
Mably, Mary S;
Zhang, Yang;
Longo, Walter L

Publication type:

Article

Propensity score matched assessment of treatment patterns and cost of erythropoiesis stimulating agent treatment in patients with cancer receiving myelosuppressive chemotherapy.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 305, doi. 10.1177/1078155212466123

By:

Tunceli, Ozgur;
Bailey, Robert A;
Stephenson, Judith J;
Singer, Joseph

Publication type:

Article

Evaluation of sources to document extended shelf lives of compounded cytostatics.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 4, p. 355, doi. 10.1177/1078155212465996

By:

Larsson, Iben;
Kart, Trine

Publication type:

Article